Project Details
Description
2022 MRFF Assessment of High-Cost Gene Treatments and Digital Health Interventions (Stream 1)
| Status | Active |
|---|---|
| Effective start/end date | 1/01/24 → 31/12/25 |
Development of a generalisable evaluation framework for high upfront-cost gene therapies: clinical, financial, ethico-legal and cultural considerations.
- Lipworth, Wendy (Chief Investigator)
- Howard, Kirsten (Primary Chief Investigator)
Project: Research